Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. - Wikidata - wikimedia - TriplyDB

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

http://www.wikidata.org/entity/Q34835409

about

Mutations in EMP2 cause childhood-onset nephrotic syndrome TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cells Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.TRPC6 in glomerular health and disease: what we know and what we believe Angiogenesis in male breast cancer Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis Podocytes Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials Kick it up a notch: Notch signaling and kidney fibrosis Role of Neuropilin-1 in Diabetic Nephropathy Angiogenic factors in preeclampsia: potential for diagnosis and treatment Oxidative stress in preeclampsia and the role of free fetal hemoglobin Cell biology and pathology of podocytes Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review Development of the Mammalian Kidney Pericytes, an overlooked player in vascular pathobiology Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients Crosstalk in glomerular injury and repair Update on the glomerular filtration barrier Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor Bmp in podocytes is essential for normal glomerular capillary formation Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.Overexpression of VEGF165b in podocytes reduces glomerular permeability.In vivo imaging of kidney glomeruli transplanted into the anterior chamber of the mouse eye.Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice FocusHeuristics - expression-data-driven network optimization and disease gene prediction

P2860

Q24297429-C860CE00-3B0A-4CAA-A043-3273D145E229 Q24300565-3CABDF1A-1C0E-400B-90D3-142E1C846706 Q24338974-AC26C2E0-D8F6-437D-ABAC-E4F6E3087251 Q24559732-25EB2263-5579-4DC4-887D-66F3299F8AEC Q24595773-26B7BFB7-8FD3-442D-A02B-957876CA488E Q24629743-8134FC7F-ACA9-422C-A7B6-14524A8EB0A6 Q24652809-BE7B920D-64A5-4889-B897-E93D4667089D Q24803467-27D2F996-9DA6-4465-90A0-7A67F4F747BB Q24804951-A4C1B81C-039F-4E87-B324-AF13252674B0 Q26743407-AC161116-0CAC-4DBE-823C-6C0A60B09A77 Q26766118-64F07E00-919F-4B0D-8988-D8E8CC9BB858 Q26796456-A0243185-AA20-4609-9490-997A85CDD639 Q26796622-1899D813-0385-4471-981A-4F978B9464D4 Q26799448-4CFDA28C-5EC0-42ED-9785-73ECD2F0EA1E Q26825774-ADE40FEB-E0E6-40DD-B39F-0B067BDE4085 Q26830141-1F3B5B98-04BF-4E43-AC82-D57FECC19A34 Q26853664-D5A37466-3E45-4F0B-865F-262F8DA53DA0 Q26865332-8880556C-1AE5-402C-A1B3-566B81D9237A Q26996084-88194A06-79DF-41C3-B500-B072A77C0707 Q27003301-F7E177A5-2834-498D-8FB7-E89DF093E676 Q27011540-D3CBE30A-C6B4-4E06-8482-50EC87827863 Q27025624-D763A0C2-2B2D-4B9B-9A51-B170225A1F54 Q28069920-1ED41134-3497-4B53-AB8F-83414AB93D63 Q28070053-C8F08458-3CE2-4987-95C2-F3689C473F74 Q28080163-C34FA931-AB23-47B2-8EC2-5ADC06EC631E Q28085092-B0A160EA-85A1-407E-A9EE-EB4E5071743E Q28241692-11AB568B-655C-4E72-9D44-25A45109E6C6 Q28256662-068355A7-5C08-4026-B3B2-2F0012D79498 Q28506573-CCB5AC11-2881-49EB-A15E-272E74D66825 Q28509980-632CA6D3-0E75-46D0-849C-34C654B22C85 Q28511751-B60A8A6B-D343-4ED4-A588-6B95B52AEE79 Q28538183-694CAC21-280A-4ACF-8C50-42172F326D74 Q28567819-6325893F-EC02-4686-BE0E-90447539617E Q30273921-4EE5FCA1-1E3B-4B40-AA32-6EDECCDCE98B Q30440705-8FC281C2-0FE0-469E-B2BB-B193EBEEEB47 Q30497786-0B34E561-4AA8-4A2D-8AD1-E4E9CA5FBBF7 Q30568956-63150878-9106-411D-A53A-E943680C974A Q31074551-0EB4B7F5-4ED4-4218-B855-890E3842C244 Q31159383-464B7320-3BDF-4999-B1BC-C33280109648 Q31162429-D2F0C0F7-F1E8-4664-AB61-6E878329AE93

P2860

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

http://www.wikidata.org/entity/Q34835409

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Glomerular-specific alteration ...... l and acquired renal diseases.

@ast

Glomerular-specific alteration ...... l and acquired renal diseases.

@en

Glomerular-specific alteration ...... l and acquired renal diseases.

@nl

type

label

Glomerular-specific alteration ...... l and acquired renal diseases.

@ast

Glomerular-specific alteration ...... l and acquired renal diseases.

@en

Glomerular-specific alteration ...... l and acquired renal diseases.

@nl

prefLabel

Glomerular-specific alteration ...... l and acquired renal diseases.

@ast

Glomerular-specific alteration ...... l and acquired renal diseases.

@en

Glomerular-specific alteration ...... l and acquired renal diseases.

@nl

P1433

Q34835409-76B9DFA4-8F4A-4070-B14A-195726C528E1

P1476

Q34835409-B98DACCB-2AB8-4B1C-B2BB-8B48E2275475

P2093

Q34835409-071A3270-ABD2-4433-93CE-E9D423A1D87D

Q34835409-5EBA0A09-91C9-4EBC-907B-2C0A534053D1

Q34835409-65A470E8-A914-4CEC-89AC-395EC7C97D8C

Q34835409-6F5E7ECC-71CE-405A-9C89-2EC2EBE5983E

Q34835409-89179D3F-08E3-42E0-8A9B-3EB8A9C080D9

Q34835409-8D70B9E3-0A1A-46EF-A171-CD7620208E93

Q34835409-902F2F36-8A0F-4B1E-834F-6399ADFE8204

Q34835409-EE01500C-D698-4CA0-A945-9480246EF6D9

Q34835409-F0CA0ED1-70EF-4CC3-B9CD-F548EF51ADA4

Q34835409-F9910E41-4EA4-4FBF-B06D-DCC18B3E82FD

P2860

Q34835409-0A7712D3-7A88-49DE-8396-C597C3E2059F

Q34835409-10505223-4768-4E2D-9312-08069473E9B0

Q34835409-119737D2-998A-4FA2-8828-F44CA0BADE2C

Q34835409-1DCBFDA1-AC3A-4F79-A87D-FBC058CE74A2

Q34835409-2D7719EF-3056-4726-BC7A-5EAE98C60040

Q34835409-2FEE8498-F225-46F3-822F-28035009C37C

Q34835409-3947C6D4-1617-4858-A324-DDAD779F8D95

Q34835409-3ABF54B7-6314-4E9B-896A-9E3E280B9729

Q34835409-4186D3E2-4103-43AA-84F7-7A9BD3634904

Q34835409-4D5A9284-A56E-4C4C-983F-C81E82E34D20

P304

Q34835409-9EFD286B-F1B2-4ACE-83FF-C8D38E7CA7EF

P31

Q34835409-98586F5B-ABA6-40A8-84BE-199FC1C24541

P356

Q34835409-0B4F8A08-7E8E-4DC2-BE28-97C29A93CAD7

P407

Q34835409-4C823925-C656-4713-8DB5-640D7CA7AD81

P433

Q34835409-E5463D07-329D-466C-A95F-8A2E38A34324

P478

Q34835409-979BCB3D-F8B5-46EE-9152-0DCA89B8AE8A

P577

Q34835409-85E334FC-8E91-4D75-9B96-FFE66CA7EDCF

P5875

Q34835409-DB7A1B02-6806-4FEC-9B7D-CBD4A3ED63FD

P698

Q34835409-3C61A669-1A5F-43B2-B679-9153D1F2C9E2

P921

Q34835409-78C4A33F-BE8E-4739-ACB0-C2D5347EC130

P932

Q34835409-F50171D3-E3D0-4867-BDD2-DBB44AFD545E

P356

P1433

Journal of Clinical Investigation

P1476

Glomerular-specific alteration ...... l and acquired renal diseases.

@en

P2093

András Nagy

http://www.w3.org/2001/XMLSchema#string

Ginette Lajoie

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Gerber

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Miner

http://www.w3.org/2001/XMLSchema#string

Jody Haigh

http://www.w3.org/2001/XMLSchema#string

Manish Sood

http://www.w3.org/2001/XMLSchema#string

Napoleone Ferrara

http://www.w3.org/2001/XMLSchema#string

Susan E Quaggin

http://www.w3.org/2001/XMLSchema#string

Vera Eremina

http://www.w3.org/2001/XMLSchema#string

Yamato Kikkawa

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165

HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis

Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells

VEGF(165) mediates glomerular endothelial repair

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision

Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.

P304

707-716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI17423

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10871461

http://www.w3.org/2001/XMLSchema#string

P698

12618525

http://www.w3.org/2001/XMLSchema#string

P921

P932

151905

http://www.w3.org/2001/XMLSchema#string